Related references
Note: Only part of the references are listed.Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
Damien Friel et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination
Carolyn M. Boudreau et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity
Ramandeep K. Virk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses
Seyhan Boyoglu-Barnum et al.
NATURE COMMUNICATIONS (2020)
Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface
Jinhui Dong et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Antibody recognition of the Pneumovirus fusion protein trimer interface
Jiachen Huang et al.
PLOS PATHOGENS (2020)
Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020
Sonja J. Olsen et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans
K. A. Richards et al.
NPJ VACCINES (2020)
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Tsun-Yung Kuo et al.
SCIENTIFIC REPORTS (2020)
Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations
Jiwon Lee et al.
CELL HOST & MICROBE (2019)
Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections
Yung-Chieh Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells
Michael S. Piepenbrink et al.
MBIO (2019)
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
Peter B. Gilbert et al.
BMC INFECTIOUS DISEASES (2019)
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
Sandhya Bangaru et al.
CELL (2019)
Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism
Akiko Watanabe et al.
CELL (2019)
Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope
Goran Bajic et al.
CELL HOST & MICROBE (2019)
MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
Sanjay S. Patel et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Development of Influenza B Universal Vaccine Candidates Using the Mosaic Hemagglutinin Approach
Weina Sun et al.
JOURNAL OF VIROLOGY (2019)
Age-specific differences in the dynamics of protective immunity to influenza
Sylvia Ranjeva et al.
NATURE COMMUNICATIONS (2019)
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
Felix Broecker et al.
NPJ VACCINES (2019)
Comparison of adjuvants to optimize influenza neutralizing antibody responses
Rebecca S. Rudicell et al.
VACCINE (2019)
Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine
Yael Bar-Peled et al.
VACCINE (2019)
Why Glycosylation Matters in Building a Better Flu Vaccine*
Deborah Chang et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
The Quest for a Truly Universal Influenza Vaccine
Yo Han Jang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice
Brigette N. Corder et al.
VACCINES (2019)
Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens
Seth J. Zost et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody
Donald D. Raymond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk
Charles J. Russell et al.
TRENDS IN MICROBIOLOGY (2018)
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
Hadi M. Yassine et al.
SCIENTIFIC REPORTS (2018)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Influenza
Florian Krammer et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
Jasmine Tomar et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Development of a Pan-H1 Influenza Vaccine
Nicole Darricarrere et al.
JOURNAL OF VIROLOGY (2018)
Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice
Felix Broecker et al.
JOURNAL OF VIROLOGY (2018)
Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
James D. Allen et al.
PLOS ONE (2018)
Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene
Nicholas C. Wu et al.
CELL HOST & MICROBE (2018)
Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs
E. R. Job et al.
NPJ VACCINES (2018)
The Doctrine of Original Antigenic Sin: Separating Good From Evil
Arnold S. Monto et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2017)
Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants
Terianne M. Wong et al.
JOURNAL OF VIROLOGY (2017)
Membrane-anchored stalk domain of influenza HA enhanced immune responses in mice
Dandan Gao et al.
MICROBIAL PATHOGENESIS (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
Masayuki Hayashi et al.
EBIOMEDICINE (2017)
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
Neal Van Hoeven et al.
SCIENTIFIC REPORTS (2017)
Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial
Zoltan Vajo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Epitope-focused vaccine design against influenza A and B viruses
Huanhuan Ren et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
A Single Mutation at Position 190 in Hemagglutinin Enhances Binding Affinity for Human Type Sialic Acid Receptor and Replication of H9N2 Avian Influenza Virus in Mice
Qiaoyang Teng et al.
JOURNAL OF VIROLOGY (2016)
Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses
Attapon Kamlangdee et al.
JOURNAL OF VIROLOGY (2016)
Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice
Huilin Ou et al.
VACCINE (2016)
Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate
Erin E. H. Tran et al.
MBIO (2016)
Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccines
Ji Yun Noh et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Different human vaccine adjuvants promote distinct antigenin-dependent immunological signatures tailored to different pathogens
Niels Peter H. Knudsen et al.
SCIENTIFIC REPORTS (2016)
Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination
J. D. Galson et al.
SCIENTIFIC REPORTS (2016)
Emerging influenza viruses and the prospect of a universal influenza virus vaccine
Florian Krammer
BIOTECHNOLOGY JOURNAL (2015)
Current and next generation influenza vaccines: Formulation and production strategies
Peter C. Soema et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hadi M. Yassine et al.
NATURE MEDICINE (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection
Yoshikazu Honda-Okubo et al.
VACCINE (2015)
ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans
Ka Yan Chung et al.
VACCINE (2015)
Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses
Teddy John Wohlbold et al.
VACCINE (2015)
Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity
Pierre-Louis Herve et al.
VIROLOGY (2015)
Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades
Corey J. Crevar et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Emerging influenza viruses and the prospect of a universal influenza virus vaccine
Florian Krammer
BIOTECHNOLOGY JOURNAL (2015)
A Viable Recombinant Rhabdovirus Lacking Its Glycoprotein Gene and Expressing Influenza Virus Hemagglutinin and Neuraminidase Is a Potent Influenza Vaccine
Alex B. Ryder et al.
JOURNAL OF VIROLOGY (2015)
Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene
Attapon Kamlangdee et al.
JOURNAL OF VIROLOGY (2014)
Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Influenza A H1N1 Pandemic Strain Evolution - Divergence and the Potential for Antigenic Drift Variants
Eili Y. Klein et al.
PLOS ONE (2014)
Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections
Juine-Ruey Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
Irina Margine et al.
JOURNAL OF VIROLOGY (2013)
Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
I. Margine et al.
JOURNAL OF VIROLOGY (2013)
Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
Bjorn F. Koel et al.
SCIENCE (2013)
Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses
Rafael A. Medina et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus
Gale E. Smith et al.
VACCINE (2013)
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2012)
Dose-range Study of MF59-adjuvanted Versus Nonadjuvanted Monovalent A/H1N1 Pandemic Influenza Vaccine in Six- to Less Than Thirty-Six-month-old Children
Stan L. Block et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Molecular basis of the structure and function of H1 hemagglutinin of influenza virus
Nongluk Sriwilaijaroen et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2012)
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
David N. Taylor et al.
VACCINE (2012)
A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects
Christoph Hatz et al.
VACCINE (2012)
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
David L. Gordon et al.
VACCINE (2012)
MF59 adjuvant: the best insurance against influenza strain diversity
Derek T. O'Hagan et al.
EXPERT REVIEW OF VACCINES (2011)
Use of defined TLR ligands as adjuvants within human vaccines
Malcolm S. Duthie et al.
IMMUNOLOGICAL REVIEWS (2011)
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets
R. Colby Layton et al.
VACCINE (2011)
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
Dan H. Barouch et al.
NATURE MEDICINE (2010)
Characterization of influenza virus sialic acid receptors in minor poultry species
Brian Kimble et al.
VIROLOGY JOURNAL (2010)
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
John Steel et al.
MBIO (2010)
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant
Eugene Maraskovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Reassortment Patterns in Swine Influenza Viruses
Hossein Khiabanian et al.
PLOS ONE (2009)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
T. Vesikari et al.
VACCINE (2009)
Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
Benoit Baras et al.
PLOS ONE (2008)
Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection
Laura Bungener et al.
VACCINE (2008)
Mapping the antigenic and genetic evolution of influenza virus
DJ Smith et al.
SCIENCE (2004)
Emergence of influenza A viruses
RJ Webby et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Share Paper
